Mar 5 |
How Much Upside is Left in GH Research PLC (GHRS)? Wall Street Analysts Think 321.28%
|
Mar 1 |
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
|
Feb 29 |
GH Research GAAP EPS of -$0.68
|
Feb 29 |
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
|
Jan 27 |
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
|
Jan 18 |
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
|
Jan 16 |
Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect?
|
Jan 12 |
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
|
Jan 7 |
Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
|
Jan 1 |
Psychedelic Stock Gainers And Losers From January 1, 2024
|